Thank you very much, Mr. Chair.
Just so that you're aware, I understand I'll be splitting my time with the parliamentary secretary.
Thank you very much to the committee members for coming.
One of the things that I feel we all too often get trapped into as a sign of success is the total dollar value in these programs. The government announces that this is how much money they've put into science and innovation this year, so it must be a success because it's more than last year or the year before.
As we've gone through this process, we've talked with several witnesses about the fact that you need more streamlined processes. It's not always about dollars and cents; sometimes you need a process that has less “bureaucratese” in it. You also need a process that has less paperwork, that's less burdensome on the smaller researchers and the smaller organizations.
Then everybody seems to get to the point--and I'd like to congratulate my colleagues like Mr. Lobb for such well-researched questions today--where you talk about the research needs in terms of how we get it from technology to commercialization, and that's the end goal.
My question is for you, Mr. MacLeod. How important is it that research is targeted at commercialization as an end goal? Is that what we should be focusing on?